Form 4: Eliem Therapeutics EVP Valerie Morisset Reports Stock Sale
SEC Form 4 Filing
Valerie Morisset, EVP, R&D and CSO of Eliem Therapeutics, sold 12,342 shares of common stock on July 5, 2024.
Summary
- On July 5, 2024, Valerie Morisset, the EVP, R&D and CSO of Eliem Therapeutics, Inc. (ELYM), sold 12,342 shares of common stock at a price of $7.06 per share.
- Following the transaction, Morisset directly owns 450,614 shares of Eliem Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider stock sale. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company's stock.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some investors, but it is a common occurrence and doesn't necessarily indicate a lack of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/05/2024 | Date of the stock sale transaction |
| 07/09/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.